Spending on U.S. medicines rose 12% in 2021 due primarily to COVID-19 vaccines and therapies

Source
IQVIA

Year
2022

Topic(s)
Covid-19

Statistic Info

COVID-19 boosted the sale of medicines during 2021, but it is projected that the growth lines are expected to return to their normal levels by 2023.

Author: IQVIA